---
title: "Romulus’ Story: A Guardian Dog’s Cancer Tale"
description: Romulus, a Maremma guardian dog, was given just 6-9 months to live after a bone cancer diagnosis. Thanks to FidoCure’s AI-driven precision medicine, he thrived for an additional four years. Learn how personalized veterinary care helped Romulus live his best life despite a tough diagnosis.
image: https://blog.fidocure.com/hubfs/Blog_PetParent_Romulus.png
---
[](https://www.fidocure.com/)
- [Veterinarians](https://fidocure.com/for-veterinarians/)
- [Portal Login](https://dvm.fidocure.com/)
- [Veterinary Blog](https://blog.fidocure.com/fidocure-blog/tag/vet)
- [Case Studies](https://blog.fidocure.com/fidocure-blog/tag/case-studies)
- [Webinars](https://blog.fidocure.com/fidocure-blog/tag/webinars)
- [Pet Parents](https://fidocure.com/pet-parents/)
- [About Us](https://fidocure.com/about-us/)
- [How it works](https://fidocure.com/how-it-works/)
- [Find a Clinic](https://fidocure.com/find-a-clinic/)
- [Contact Us](https://fidocure.com/contact-us/)
# Romulus’ Story: A Guardian Dog’s Cancer Tale
[FidoCure](https://blog.fidocure.com/fidocure-blog/author/fidocure)
[Share this blog post on Twitter](https://twitter.com/intent/tweet?text=I+found+this+interesting+blog+post&url=https://blog.fidocure.com/fidocure-blog/romulus-story-a-guardian-dogs-tale) [Share this blog post on Facebook](http://www.facebook.com/share.php?u=https://blog.fidocure.com/fidocure-blog/romulus-story-a-guardian-dogs-tale) [Share this blog post on LinkedIn](http://www.linkedin.com/shareArticle?mini=true&url=https://blog.fidocure.com/fidocure-blog/romulus-story-a-guardian-dogs-tale)
At FidoCure, we believe every dog deserves a chance to live their best life, even when faced with challenging diagnoses. The story of Romulus, a beloved Maremma guardian dog, is a testament to the power of personalized veterinary care.
When Romulus was initially diagnosed with bone cancer, his primary veterinarian, Dr. Jennifer Enger at Mid-Hudson Veterinary Practice, recommended amputation. While amputation is the most common treatment for canine bone cancer, it would have significantly impaired Romulus' quality of life, as he was a dedicated protector of his family's chicken coops. The original prognosis estimated that Romulus had just 6-9 months to live—a devastating outlook for a dog known for his big smile and friendly demeanor.
However, Romulus' family and Dr. Enger were not ready to give up on him and decided to enroll him in the FidoCure platform. Through our innovative approach, we provided an AI-driven precision medicine treatment plan that exceeded initial expectations. Instead of the anticipated 6-9 month timeline, Romulus thrived for an additional four years. These extra years allowed his family to spend more precious time with their beloved dog and enabled Romulus to continue his important work of guarding the farm and helping train the next generation of puppies.
As the O'Donohue family shared, "Without Christina Lopes and her passion to help dogs with bone cancer, Romulus' diagnosis would have been grave. Thanks to Christina and the amazing FidoCure team, Romulus lived an additional four years with targeted therapy treatment guided by FidoCure's precision medicine platform and helped train our puppies."
Romulus has since passed, but he is fondly remembered by his four-pawed friends and the humans who knew him. His story serves as a powerful reminder of the significant difference that AI-driven precision medicine can make.
To the O'Donohue family and all the pet parents who trust us with the care of their beloved pets: thank you. Your faith in our mission inspires us to continue pushing boundaries and setting new standards for veterinary oncology.
## Related Articles
[](https://blog.fidocure.com/fidocure-blog/transitional-cell-carcinoma-case-study-ruby)
[Case Studies](https://blog.fidocure.com/fidocure-blog/tag/case-studies)
### [Transitional Cell Carcinoma Case Study: Ruby](https://blog.fidocure.com/fidocure-blog/transitional-cell-carcinoma-case-study-ruby)
#### With the help of FidoCure® therapy, Ruby had a great quality of life for 2 years after her initial diagnosis of transitional cell carcinoma.
[Dr. Dorothy Jackson Girimonte](https://blog.fidocure.com/fidocure-blog/author/dr-dorothy-jackson-girimonte)
[Read More](https://blog.fidocure.com/fidocure-blog/transitional-cell-carcinoma-case-study-ruby)
[](https://blog.fidocure.com/fidocure-blog/fidocure-r-case-study-callie-augur)
[Case Studies](https://blog.fidocure.com/fidocure-blog/tag/case-studies)
### [Jejunal Adenocarcinoma Case Study: Callie](https://blog.fidocure.com/fidocure-blog/fidocure-r-case-study-callie-augur)
#### With surgery and FidoCure® therapy, Callie is alive and well almost 20 months after her initial diagnosis of jejunal adenocarcinoma.
[Dr. Dorothy Jackson Girimonte](https://blog.fidocure.com/fidocure-blog/author/dr-dorothy-jackson-girimonte)
[Read More](https://blog.fidocure.com/fidocure-blog/fidocure-r-case-study-callie-augur)
- [How it Works](https://fidocure.com/how-it-works/)
- [FAQ](https://fidocure.com/faq/)
- [Contact Us](https://fidocurestg.wpengine.com/contact-us/)
- [For Vets](https://fidocure.com/for-veterinarians/)
- [About Us](https://fidocure.com/about-us/)
- [Terms of Service](https://fidocure.com/terms-of-service/)
- [Blog](https://blog.fidocure.com/fidocure-blog)
- [Careers](https://fidocure.com/careers/)
- [Privacy Policy](https://fidocure.com/privacy-policy/)
-
-
-
-
**FidoCure® is an advanced cancer-care service for dogs, developed by One Health Company**. DISCLAIMER: All patients are enrolled in FidoCure® by a veterinarian with a valid veterinarian-client-patient relationship (VCPR). We use best efforts to inform the veterinarian on available targeted therapy options for patients. FidoCure® does not prescribe therapy. The targeted therapies that veterinarians may prescribe and order from compounding pharmacies, after receiving genetic test results from FidoCure®, may constitute extra-label uses of those drugs. FidoCure® makes no claims that every patient will have genetic test results that lead to targeted therapy options. FidoCure® makes no claims or guarantees about the effectiveness of the diagnostic and targeted therapy selected by the veterinarian for an individual patient. Like most cancer care approaches, the services provided by FidoCure® are not a guarantee of a cure. FidoCure® is not a pharmacy and does not supply drugs directly. By ordering any medication via one of our pharmacy partners, you agree that the pharmacy, not FidoCure®, is solely responsible and liable for any and all issues relating to the preparation, dispensation and fulfillment of the medication. The lifetime offer is subject to the commercially reasonable availability of any medication(s) and/or active pharmaceutical ingredient(s) necessary for the selected therapy.
© Copyright 2018-2026 One Health Company, All rights reserved
```json
{
"@context" : "https://schema.org",
"@type" : "BlogPosting",
"author" : {
"@type" : "Person",
"name" : "FidoCure",
"url" : "https://blog.fidocure.com/fidocure-blog/author/fidocure"
},
"dateModified" : "2024-12-17T16:22:42.739Z",
"datePublished" : "2024-12-17T16:16:37.000Z",
"headline" : "Romulus’ Story: A Guardian Dog’s Cancer Tale",
"image" : [ "https://blog.fidocure.com/hubfs/Blog_PetParent_Romulus.png" ],
"mainEntityOfPage" : {
"@id" : "https://blog.fidocure.com/fidocure-blog/romulus-story-a-guardian-dogs-tale",
"@type" : "WebPage"
},
"publisher" : {
"@type" : "Organization",
"logo" : {
"@type" : "ImageObject",
"url" : "https://blog.fidocure.com/hubfs/fidocure_logo.png"
},
"name" : "FidoCure"
}
}
```